Response to benralizumab in patients with severe eosinophilic asthma.

Velasco-Santos JI, Núñez-Martínez FJ, Martínez-Sánchez BH, Chávez-Lárraga AJ

Open source

DOI
10.5281/zenodo.19076191
Published
2026 Jul 13
Container
Revista medica del Instituto Mexicano del Seguro Social
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5281/zenodo.19076191,
  title = {Response to benralizumab in patients with severe eosinophilic asthma.},
  author = {Velasco-Santos JI and Núñez-Martínez FJ and Martínez-Sánchez BH and Chávez-Lárraga AJ},
  year = {2026},
  journal = {Revista medica del Instituto Mexicano del Seguro Social},
  doi = {10.5281/zenodo.19076191},
  url = {https://doi.org/10.5281/zenodo.19076191}
}

RIS

TY  - JOUR
TI  - Response to benralizumab in patients with severe eosinophilic asthma.
AU  - Velasco-Santos JI
AU  - Núñez-Martínez FJ
AU  - Martínez-Sánchez BH
AU  - Chávez-Lárraga AJ
PY  - 2026
JO  - Revista medica del Instituto Mexicano del Seguro Social
DO  - 10.5281/zenodo.19076191
UR  - https://doi.org/10.5281/zenodo.19076191
ER  - 

APA

JI, V., FJ, N., BH, M., & AJ, C. (2026). Response to benralizumab in patients with severe eosinophilic asthma.. Revista medica del Instituto Mexicano del Seguro Social. https://doi.org/10.5281/zenodo.19076191

Source records